Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatment

The treatment for hepatocellular carcinoma (HCC) relies on liver resection, which is, however, burdened by a high rate of recurrence after surgery, up to 60% at 5 years. No pre-operative tools are currently available to assess the recurrence risk tailored to every single patient. Recently liquid bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Carissimi, Francesca, Barbaglia, Matteo Nazzareno, Salmi, Livia, Ciulli, Cristina, Roccamatisi, Linda, Cordaro, Giuseppe, Mallela, Venkata Ramana, Minisini, Rosalba, Leone, Biagio Eugenio, Donadon, Matteo, Torzilli, Guido, Pirisi, Mario, Romano, Fabrizio, Famularo, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462072/
https://www.ncbi.nlm.nih.gov/pubmed/34621473
http://dx.doi.org/10.4240/wjgs.v13.i9.967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8462072/
https://www.ncbi.nlm.nih.gov/pubmed/34621473
http://dx.doi.org/10.4240/wjgs.v13.i9.967

Ejemplares similares